Dong-xian Guan
320 Yueyang Road
Yueyang, 200031, China
Yueyang, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 27, 2021
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Journal: Cell proliferation
Published: September 02, 2018
CHML promotes liver cancer metastasis by facilitating Rab14 recycle.
Journal: Nature communications
Published: December 27, 2017
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
Journal: British journal of cancer
Published: October 02, 2017
Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
Journal: The Journal of experimental medicine
Published: March 02, 2017
Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis.
Journal: Journal of hepatology
Published: July 08, 2015
Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.
Journal: Hepatology (Baltimore, Md.)
Published: March 05, 2015
Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 27, 2013
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
Journal: Journal of hepatology
Published: January 21, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026